ZETASET Trademark

Trademark Overview

On Monday, April 18, 2022, a trademark application was filed for ZETASET with the United States Patent and Trademark Office. The USPTO has given the ZETASET trademark a serial number of 97367600. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, August 21, 2024. This trademark is owned by Zetagen Therapeutics, Inc.. The ZETASET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of bone diseases
zetaset

General Information

Serial Number97367600
Word MarkZETASET
Filing DateMonday, April 18, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of bone diseases
Pseudo MarkZETA SET

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZetagen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSyracuse, NY 13210
Party NameZetagen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSyracuse, NY 13210

Trademark Events

Event DateEvent Description
Thursday, June 30, 2022ASSIGNED TO EXAMINER
Thursday, April 21, 2022NEW APPLICATION ENTERED
Friday, April 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 13, 2023SOU EXTENSION 1 FILED
Monday, March 13, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 14, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 14, 2023SOU EXTENSION 2 FILED
Thursday, September 14, 2023SOU EXTENSION 2 GRANTED
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Tuesday, February 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 20, 2024SOU EXTENSION 3 GRANTED
Saturday, September 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU EXTENSION 4 FILED
Wednesday, August 21, 2024SOU EXTENSION 4 GRANTED
Tuesday, February 20, 2024SOU EXTENSION 3 FILED

Related Keywords

zetaset diseases bone treatment products pharmaceutical